| Primary |
| Drug Use For Unknown Indication |
31.3% |
| Product Used For Unknown Indication |
10.6% |
| Atrial Fibrillation |
9.4% |
| Blood Pressure Increased |
6.0% |
| Tachycardia |
6.0% |
| Maintenance Of Anaesthesia |
5.3% |
| Anaesthesia |
3.8% |
| Anaesthetic Premedication |
3.4% |
| Blood Pressure Decreased |
3.4% |
| Hypotonia |
3.0% |
| Off Label Use |
2.6% |
| Neuromuscular Blockade Reversal |
2.3% |
| Endotracheal Intubation |
1.9% |
| Induction Of Anaesthesia |
1.9% |
| Infection Prophylaxis |
1.9% |
| Ventricular Arrhythmia |
1.9% |
| General Anaesthesia |
1.5% |
| Oesophageal Dilation Procedure |
1.5% |
| Cardiac Failure |
1.1% |
| Cardioversion |
1.1% |
|
| Cardiac Arrest |
20.4% |
| Drug Ineffective |
10.2% |
| Blindness |
6.1% |
| Cerebral Infarction |
6.1% |
| Death |
6.1% |
| Shock |
6.1% |
| Vascular Injury |
6.1% |
| Ventricular Fibrillation |
6.1% |
| Bradycardia |
4.1% |
| Drug Intolerance |
4.1% |
| Multi-organ Failure |
4.1% |
| Paranoia |
4.1% |
| Atrioventricular Block |
2.0% |
| Blindness Transient |
2.0% |
| Depressed Level Of Consciousness |
2.0% |
| Device Failure |
2.0% |
| Drug Toxicity |
2.0% |
| Hyponatraemia |
2.0% |
| Necrosis |
2.0% |
| Neurotoxicity |
2.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
23.3% |
| Ventricular Arrhythmia |
16.8% |
| Tachycardia |
15.6% |
| Off Label Use |
15.1% |
| Blood Pressure Increased |
3.6% |
| Product Used For Unknown Indication |
3.6% |
| Atrial Fibrillation |
3.4% |
| Mineral Supplementation |
2.9% |
| General Anaesthesia |
2.4% |
| Neuromuscular Blockade Reversal |
2.4% |
| Anaesthesia |
1.9% |
| Induction Of Anaesthesia |
1.4% |
| Ventricular Tachycardia |
1.4% |
| Cardiac Output Decreased |
1.0% |
| Heart Rate Decreased |
1.0% |
| Poor Peripheral Circulation |
1.0% |
| Positive Cardiac Inotropic Effect |
1.0% |
| Torsade De Pointes |
1.0% |
| Cardioversion |
0.7% |
| Hypotonia |
0.7% |
|
| Drug Intolerance |
65.9% |
| Cardiac Arrest |
10.2% |
| Drug Ineffective |
4.5% |
| Neurotoxicity |
4.5% |
| Depressed Level Of Consciousness |
2.3% |
| Multi-organ Failure |
2.3% |
| Atrioventricular Block |
1.1% |
| Blindness Transient |
1.1% |
| Drug Toxicity |
1.1% |
| Hyponatraemia |
1.1% |
| Medication Error |
1.1% |
| Shock |
1.1% |
| Skin Ulcer |
1.1% |
| Therapy Cessation |
1.1% |
| Therapy Non-responder |
1.1% |
|
| Concomitant |
| Prophylaxis |
18.1% |
| Anaesthesia |
11.3% |
| Analgesia |
6.7% |
| Deep Vein Thrombosis |
6.7% |
| Maintenance Of Anaesthesia |
5.9% |
| Bradycardia |
5.0% |
| Sedation |
5.0% |
| Induction Of Anaesthesia |
3.8% |
| Pain Prophylaxis |
3.8% |
| Tachycardia |
3.8% |
| Blood Pressure Increased |
3.4% |
| Hypotonia |
3.4% |
| Infection Prophylaxis |
3.4% |
| Pyrexia |
3.4% |
| Cardiovascular Event Prophylaxis |
2.9% |
| Catheterisation Cardiac |
2.9% |
| Coronary Artery Bypass |
2.9% |
| Fluid Replacement |
2.5% |
| Hypertension |
2.5% |
| Mineral Supplementation |
2.5% |
|
| Depressed Level Of Consciousness |
17.6% |
| Upper Respiratory Tract Infection |
11.8% |
| Sepsis |
8.8% |
| Tachyarrhythmia |
8.8% |
| Heart Rate Increased |
5.9% |
| Weight Decreased |
5.9% |
| Anhedonia |
2.9% |
| Arthritis |
2.9% |
| Blood Alkaline Phosphatase Increased |
2.9% |
| Fear |
2.9% |
| Gastrointestinal Haemorrhage |
2.9% |
| Hypernatraemia |
2.9% |
| Injury |
2.9% |
| Joint Swelling |
2.9% |
| Lower Gastrointestinal Haemorrhage |
2.9% |
| Multi-organ Failure |
2.9% |
| Pain |
2.9% |
| Psychiatric Symptom |
2.9% |
| Renal Injury |
2.9% |
| Stress |
2.9% |
|
